March 25, 2018
[FDG PET Helps] Determining the Effectiveness of Anti-PD1 Treatment in Hodgkin Lymphoma Patients
Three-month 18F-FDG PET/CT imaging helps detect which patients with Hodgkin lymphoma (HL) respond to immune-checkpoint blockade by anti–programmed death 1 antibodies (anti-PD1), according to a study published in the Journal of Nuclear Medicine. {read more here}